Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.76 USD | +0.79% | -1.63% | -9.30% |
05-01 | RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept | MT |
04-30 | Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.30% | 6.34B | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.85% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Sees Fiscal 2023 Revenue at Lower End of Guidance; Issues Fiscal 2024 Revenue Outlook